Cidel Asset Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,510
Closed -$218K 159
2022
Q4
$218K Sell
4,510
-22,168
-83% -$973K 0.01% 145
2022
Q3
$1.01M Sell
26,678
-475,403
-95% -$21.2M 0.05% 85
2022
Q2
$25.1M Buy
502,081
+53,775
+12% +$2.85M 1.07% 34
2022
Q1
$23M Sell
448,306
-103,684
-19% -$5.35M 0.84% 41
2021
Q4
$27.7M Sell
551,990
-5,305
-1% -$262K 1.03% 33
2021
Q3
$26.9M Buy
557,295
+42,259
+8% +$2.15M 1.09% 30
2021
Q2
$27.1M Buy
515,036
+350,417
+213% +$18.3M 1.1% 31
2021
Q1
$8.14M Buy
164,619
+24,603
+18% +$1.18M 0.37% 57
2020
Q4
$6.8M Sell
140,016
-23,026
-14% -$1.14M 0.38% 56
2020
Q3
$8.18M Buy
163,042
+1,550
+1% +$79.8K 0.47% 54
2020
Q2
$8.24M Buy
161,492
+151,462
+1,510% +$7.36M 0.37% 57
2020
Q1
$439K Buy
10,030
+2,220
+28% +$106K 0.02% 80
2019
Q4
$392K Sell
7,810
-1,426
-15% -$66.8K 0.02% 89
2019
Q3
$428K Buy
9,236
+1,819
+25% +$78.4K 0.02% 104
2019
Q2
$321K Buy
7,417
+1,551
+26% +$66K 0.02% 87
2019
Q1
$260K Buy
5,866
+754
+15% +$32.3K 0.01% 113
2018
Q4
$222K Buy
+5,112
New +$225K 0.01% 99

Other funds holding SNY

Cidel Asset Management's SNY Position: Q1 2023 in Review

Cidel Asset Management sold out of Sanofi (SNY) in Q1 2023, closing a stake of 4,510 shares — an estimated $218K sold.

Cidel Asset Management first reported a position in SNY in Q4 2018 and held it in 17 quarters. The position peaked at $27.7M in Q4 2021. 678 funds tracked by Wall St. Rank hold SNY as of Q1 2023.

  • Cidel Asset Management reported no remaining Sanofi position as of Q1 2023 after selling out during the quarter.
  • Cidel Asset Management sold 4,510 Sanofi shares in Q1 2023, an estimated $218K.
  • Cidel Asset Management first reported a position in Sanofi in Q4 2018 and held it in 17 quarters.
  • Cidel Asset Management's Sanofi position peaked at $27.7M in Q4 2021.
  • 678 funds tracked by Wall St. Rank held Sanofi as of Q1 2023.

Based on Cidel Asset Management's 13F filing for Q1 2023, filed 5 May 2023.